首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical cancer research

缩写:CLIN CANCER RES

ISSN:1078-0432

e-ISSN:1557-3265

IF/分区:10.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引11950条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sebastian Medina,Naoto Tokuyama,Vaishnavi Putcha et al. Sebastian Medina et al.
Purpose: The ENZAMET trial established that enzalutamide added to androgen deprivation therapy (ADT) improves overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC), but treatment response is hetero...
Lazar Vujanovic,Pedro Torres-Saavedra,Fei Tu et al. Lazar Vujanovic et al.
Purpose: Patients with pathologically high-risk, HPV-negative HNSCC recur frequently despite adjuvant cisplatin-radiation therapy (CRT). As CRT can upregulate PD-1/L1 immune checkpoints, adding pembrolizumab may reverse t...
Matteo Repetto,Allison L Richards,Monica F Chen et al. Matteo Repetto et al.
Purpose: MYC, MYCN and MYCL amplifications are recurrent oncogenic events across solid tumors. Currently, no standardized selection biomarker is available to identify patients with MYC-dependent tumors. ...
Daniel Nguyen,Hagop M Kantarjian,Aram Bidikian et al. Daniel Nguyen et al.
Purpose: Outcomes in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) remain discouraging despite rapid expansion of treatment paradigms over the past decade. Clinicians must often decide between conve...
Navin Pinto,Annette Künkele,Catherine M Albert et al. Navin Pinto et al.
Purpose: Outcomes for children with relapsed and refractory neuroblastoma are dismal. ENCIT-01 (NCT02311621) was a first-in-human clinical trial for patients with relapsed and refractory neuroblastoma using chimeric antig...
Jia Li Low,Wan Qin Chong,Edwin Pun Hui et al. Jia Li Low et al.
Purpose: Therapeutic options beyond platinum, gemcitabine and immunotherapy in r/m NPC remain limited. Median overall survival for R/M disease is 20 months. This study evaluated the efficacy and safety of FTD/TPI in plati...
Marcelo Jimenez,Beryl A Hatton,Alicia Moreno-Gonzalez et al. Marcelo Jimenez et al.
Purpose: This treat-and-resect clinical study evaluated a specialized form of pulsed electric field (PEF) ablation's potential to modulate antitumor immunity in early-stage non-small cell lung cancer (NSCLC). Tertiary lym...